LMAT
What one share of Lemaitre Vascular holds
Surgical and Medical Instruments and Apparatus
We are a global provider of medical devices and human tissue cryopreservation services largely used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. We develop, manufacture, and market vascular devices to address the needs of vascular surgeons and, to a lesser degree, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons.
Lemaitre Vascular’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $11.06 |
|---|---|
| Profit | $2.77 |
| Capex (buildings and equipment) | $0.39 |
| Free cash flow | $3.11 |
| Dividends | $0.90 |
| Cash and investments | $1.16 |
| Book value | $18.38 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $4.63 | $0.55 | $0.15 | $0.73 | $0.18 | $4.69 |
| 2017 | $5.04 | $0.86 | $0.32 | $0.82 | $0.22 | $5.69 |
| 2018 | $5.22 | $1.13 | $0.15 | $0.81 | $0.28 | $6.98 |
| 2019 | $5.77 | $0.88 | $0.18 | $0.51 | $0.34 | $7.34 |
| 2020 | $6.32 | $1.04 | $0.15 | $1.55 | $0.38 | $8.41 |
| 2021 | $7.19 | $1.25 | $0.23 | $1.41 | $0.44 | $11.59 |
| 2022 | $7.29 | $0.93 | $0.15 | $1.00 | $0.50 | $12.14 |
| 2023 | $8.63 | $1.34 | $0.32 | $1.31 | $0.56 | $13.34 |
| 2024 | $9.65 | $1.93 | $0.31 | $1.63 | $0.64 | $14.96 |
| 2025 | $10.89 | $2.52 | $0.30 | $3.25 | $0.80 | $17.28 |